TENOFOVIR DISOPROXIL FUMARATE
- Product NDC
- 70518-1002
- 11-digit product format
- 705181002
- Labeler code
- 70518
- Product ID
- 70518-1002_cf2f3048-a547-7cf0-e053-2a95a90a2250
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tenofovir disoproxil fumarate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090742
- Marketing category
- ANDA
- Marketing start
- 2018-02-02
- Marketing end
- 0000-00-00
- Substance
- TENOFOVIR DISOPROXIL FUMARATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1002-0 | 70518100200 | 30 TABLET in 1 BLISTER PACK (70518-1002-0) | 30 tablet | 2018-02-02 | 0000-00-00 | No | No | Current |
| 70518-1002-1 | 70518100201 | 4 TABLET in 1 BLISTER PACK (70518-1002-1) | 4 tablet | 2019-01-31 | 0000-00-00 | No | No | Current |